中国P站

Journal of Infectious Disease and Pathology
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Axel Cloeckaert INRAE

INRAE, Universit脙漏 de Tours, France
Publications

SC Pembrolizumab: IV Non-Inferiority, Patient Convenience

The KEYNOTE-A18 trial is a Phase 3, randomized, non-inferiority study assessing subcutaneous (SC) pembrolizumab (MK- 3475A with hyaluronidase) versus intravenous (IV) pembrolizumab for advanced melanoma, NSCLC, RCC, HNSCC, and UC. It enrolled 1756 patients, comparing 600 mg SC Q6W with standard IV dosing. Primary endpoints include PK equivalence (C... Read More»

Axel Cloeckaert INRAE

: J Infect Pathol 08: 314

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.